Literature DB >> 32375598

Temporal Acute Serum Estradiol and Tumor Necrosis Factor-α Associations and Risk of Death after Severe Traumatic Brain Injury.

Raj G Kumar1,2, Dominic DiSanto1, Nabil Awan3, Leah E Vaughan1, Marina S Levochkina1, Justin L Weppner1, David W Wright4, Sarah L Berga5, Yvette P Conley6, Maria M Brooks2, Amy K Wagner1,7,8.   

Abstract

Severe traumatic brain injury (TBI) activates a robust systemic response that involves inflammatory and other factors, including estradiol (E2), associated with increased deaths. Tumor necrosis factor-alpha (TNFα) is a significant mediator of systemic shock, and it is an extra-gonadal transcription factor for E2 production. The study objectives were to test the hypotheses: (1) a positive feedback relationship exists between acute serum TNFα and E2; and (2) acute concentrations of E2 and TNFα are prognostic indicators of death after severe TBI. This prospective cohort study included N = 157 adults with severe TBI. Serum samples were collected for the first five days post-injury. The TNFα and E2 levels were averaged into two time epochs: first 72 h (T1) and second 72 h post-injury (T2). A cross-lag panel analysis conducted between T1 and T2 TNFα and E2 levels showed significant cross-lag effects: T1 TNFα and T1 E2 were related to T2 E2 and T2 TNFα, respectively. Cox proportional hazards multi variable regression models determined that increases in T1 E2 (hazard ratio [HR] = 1.79, 95% confidence interval [CI]: 1.15, 2.81), but not T2 E2 (HR = 0.91, 95% CI: 0.56, 1.47), were associated with increased risk of death. Increased T2 TNFα (HR = 2.47, 95% CI: 1.35, 4.53), and T1 TNFα (HR = 1.47, 95% CI: 0.99, 2.19), to a lesser degree, were associated with increased risk of death. Relationships of death with T2 TNFα and T1 E2 were mediated partially by cardiovascular, hepatic, and renal dysfunction. Both E2 and TNFα are systemic, reciprocally related biomarkers that may be indicative of systemic compromise and increased risk of death after severe TBI.

Entities:  

Keywords:  estradiol; non-neurological organ dysfunction; systemic trauma complex; traumatic brain injury; tumor necrosis factor-alpha

Year:  2020        PMID: 32375598      PMCID: PMC7580589          DOI: 10.1089/neu.2019.6577

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  80 in total

Review 1.  The acute phase response.

Authors:  H Baumann; J Gauldie
Journal:  Immunol Today       Date:  1994-02

2.  Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue.

Authors:  M C Morganti-Kossman; P M Lenzlinger; V Hans; P Stahel; E Csuka; E Ammann; R Stocker; O Trentz; T Kossmann
Journal:  Mol Psychiatry       Date:  1997-03       Impact factor: 15.992

3.  Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study.

Authors:  Bernd Maier; Helmut-Leopold Laurer; Stefan Rose; W A Buurman; Ingo Marzi
Journal:  J Neurotrauma       Date:  2005-07       Impact factor: 5.269

4.  Assessment of coma and impaired consciousness. A practical scale.

Authors:  G Teasdale; B Jennett
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

Review 5.  Corticosteroids for acute traumatic brain injury.

Authors:  P Alderson; I Roberts
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

6.  17β-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release.

Authors:  Kewen Zhou; Qi Gao; Shuhui Zheng; Sinian Pan; Ping Li; Kun Suo; Tommaso Simoncini; Tinghuai Wang; Xiaodong Fu
Journal:  Mol Hum Reprod       Date:  2012-10-05       Impact factor: 4.025

7.  Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.

Authors:  C Martin; C Boisson; M Haccoun; L Thomachot; J L Mege
Journal:  Crit Care Med       Date:  1997-11       Impact factor: 7.598

8.  Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.

Authors:  David P Stirling; Kourosh Khodarahmi; Jie Liu; Lowell T McPhail; Christopher B McBride; John D Steeves; Matt S Ramer; Wolfram Tetzlaff
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

9.  Serum tumor necrosis factor levels in patients with infectious disease and septic shock.

Authors:  F Offner; J Philippé; D Vogelaers; F Colardyn; G Baele; M Baudrihaye; A Vermeulen; G Leroux-Roels
Journal:  J Lab Clin Med       Date:  1990-07

Review 10.  Sources of estrogen and their importance.

Authors:  E R Simpson
Journal:  J Steroid Biochem Mol Biol       Date:  2003-09       Impact factor: 4.292

View more
  3 in total

1.  17α-Ethinyl estradiol-3-sulfate increases survival and hemodynamic functioning in a large animal model of combined traumatic brain injury and hemorrhagic shock: a randomized control trial.

Authors:  Andrew R Mayer; Andrew B Dodd; Julie G Rannou-Latella; David D Stephenson; Rebecca J Dodd; Josef M Ling; Carissa J Mehos; Cidney R Robertson-Benta; Sharvani Pabbathi Reddy; Rachel E Kinsler; Meghan S Vermillion; Andrew P Gigliotti; Veronik Sicard; Amy L Lloyd; Erik B Erhardt; Jessica M Gill; Chen Lai; Vivian A Guedes; Irshad H Chaudry
Journal:  Crit Care       Date:  2021-12-16       Impact factor: 9.097

2.  Ovariectomy Affects Acute Pancreatitis in Mice.

Authors:  Melinda Wang; Fred Gorelick
Journal:  Dig Dis Sci       Date:  2021-06-24       Impact factor: 3.487

3.  Plasma 1,3-β-d-glucan levels predict adverse clinical outcomes in critical illness.

Authors:  Georgios D Kitsios; Daniel Kotok; Haopu Yang; Malcolm A Finkelman; Yonglong Zhang; Noel Britton; Xiaoyun Li; Marina S Levochkina; Amy K Wagner; Caitlin Schaefer; John J Villandre; Rui Guo; John W Evankovich; William Bain; Faraaz Shah; Yingze Zhang; Barbara A Methé; Panayiotis V Benos; Bryan J McVerry; Alison Morris
Journal:  JCI Insight       Date:  2021-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.